Cytokinetics Inc (NASDAQ:CYTK)
| 38.18 Delayed Data As of 4:00pm ET |  -1.66 / -4.17%Today’s Change | 17.72 Today|||52-Week Range 47.90 | -16.24% Year-to-Date |
Latest CYTK News | Press Releases
| HealthCor Management, L.P. Buys 2, Sells 3 in 1st Quarter May 18 / GuruFocus News - Paid Partner Content |
Today’s Trading
| Previous close | 39.84 |
| Today’s open | 38.90 |
| Day’s range | 37.60 - 38.94 |
| Volume | 32,792 |
| Average volume (3 months) | 1,006,664 |
| Market cap | $3.4B |
Data as of 4:00pm ET, 05/24/2022
Growth & Valuation
| Earnings growth (last year) | -41.95% |
| Earnings growth (this year) | -56.59% |
| Earnings growth (next 5 years) | +1.00% |
| Revenue growth (last year) | +26.15% |
| P/E ratio | NM |
| Price/Sales | 49.76 |
| Price/Book | 13.84 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| GRFSGrifols SA | +0.17 | +1.30% |
| RAREUltragenyx Pharmaceu... | -2.11 | -4.40% |
| ---- | ||
| MRTXMirati Therapeutics ... | -4.70 | -7.40% |
Data as of 4:00pm ET, 05/24/2022
Financials
| Next reporting date | August 4, 2022 |
| EPS forecast (this quarter) | -$1.03 |
| Annual revenue (last year) | $70.4M |
| Annual profit (last year) | -$215.3M |
| Net profit margin | -305.72% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters South San Francisco, California |
Forecasts
